Explore comprehensive CDMO services offered by HitGen Inc, supporting end-to-end Anlaytical Testing, Clinical Studies, Drug Development, Drug Discovery and Manufacturing. HitGen Inc enables faster, compliant, and scalable pharma innovation tailored to your needs.
Country: China
Description: HitGen Inc. is a China-based biotech and CDMO specializing in drug discovery and early-stage development. It offers DNA-encoded library (DEL) screening, fragment-based and structure-based drug design, medicinal chemistry, and assay development. Its CDMO arm, Hitston, provides GMP-compliant manufacturing of nucleic-acid therapeutics (oligonucleotides) from R&D to IND/clinical scale. HitGen collaborates globally with pharma and biotech partners but does not focus on large-scale small-molecule or biologics manufacturing.
